{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:34:58Z","timestamp":1757612098887,"version":"3.44.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7759\/cureus.91575","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:36:27Z","timestamp":1756967787000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of Prostate-Specific Membrane Antigen (PSMA) PET-CT in Characterizing Suspected Synchronous Rectal Lesions in a Case of High-Grade Prostatic Adenocarcinoma"],"prefix":"10.7759","author":[{"given":"Gowri","family":"Sankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swarnava","family":"Tarafdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anindya","family":"Halder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rama","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Tummidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-023-04002-z","article-title":"PSMA PET imaging in the diagnosis and management of prostate cancer","volume":"48","author":"Houshmand S","year":"2023","unstructured":"Houshmand S, Lawhn-Heath C, Behr S. PSMA PET imaging in the diagnosis and management of prostate cancer. Abdom Radiol (NY). 2023, 48:3610-23. 10.1007\/s00261-023-04002-z","journal-title":"Abdom Radiol (NY)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06089-w","article-title":"PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0","volume":"50","author":"Fendler WP","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, et al.. PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging. 2023, 50:1466-86. 10.1007\/s00259-022-06089-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.02.002","article-title":"Second version of the Prostate Cancer Molecular Imaging Standardized Evaluation framework including response evaluation for clinical trials (PROMISE V2)","volume":"83","author":"Seifert R","year":"2023","unstructured":"Seifert R, Emmett L, Rowe SP, et al.. Second version of the Prostate Cancer Molecular Imaging Standardized Evaluation framework including response evaluation for clinical trials (PROMISE V2). Eur Urol. 2023, 83:405-12. 10.1016\/j.eururo.2023.02.002","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa F","year":"2020","unstructured":"de Galiza Barbosa F, Queiroz MA, Nunes RF, et al.. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020, 20:23. 10.1186\/s40644-020-00300-7","journal-title":"Cancer Imaging"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001072","article-title":"Rectal carcinoma on 68Ga-PSMA PET\/CT","volume":"41","author":"Huang YT","year":"2016","unstructured":"Huang YT, Fong W, Thomas P. Rectal carcinoma on 68Ga-PSMA PET\/CT. Clin Nucl Med. 2016, 41:e167-8. 10.1097\/RLU.0000000000001072","journal-title":"Clin Nucl Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000001484","article-title":"Strong PSMA radioligand uptake by rectal carcinoma: who put the \u201cS\u201d in PSMA?","volume":"42","author":"Stoykow C","year":"2017","unstructured":"Stoykow C, Huber-Schumacher S, Almanasreh N, Jilg C, Ruf J. Strong PSMA radioligand uptake by rectal carcinoma: who put the \u201cS\u201d in PSMA?. Clin Nucl Med. 2017, 42:225-6. 10.1097\/RLU.0000000000001484","journal-title":"Clin Nucl Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000004066","article-title":"68Ga-PSMA PET\/CT scan leading to diagnosis of PSMA-positive rectal adenocarcinoma in a patient with prostate cancer","volume":"47","author":"Norouzi G","year":"2022","unstructured":"Norouzi G, Rezaei A, Adinehpour Z, Amini H, Vali R. 68Ga-PSMA PET\/CT scan leading to diagnosis of PSMA-positive rectal adenocarcinoma in a patient with prostate cancer. Clin Nucl Med. 2022, 47:e323-4. 10.1097\/RLU.0000000000004066","journal-title":"Clin Nucl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13139-021-00732-4","article-title":"[68 GA]GA-PSMA-11 small bowel uptake in Crohn\u2019s disease: revisiting the \u201cnon-specificity\u201d of PSMA ligands","volume":"56","author":"Chandekar KR","year":"2022","unstructured":"Chandekar KR, Tanigassalam S, Kavanal AJ, Singh H, Bhattacharya A, Mavuduru RS. [68 GA]GA-PSMA-11 small bowel uptake in Crohn\u2019s disease: revisiting the \u201cnon-specificity\u201d of PSMA ligands. Nucl Med Mol Imaging. 2022, 56:102-4. 10.1007\/s13139-021-00732-4","journal-title":"Nucl Med Mol Imaging"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S404009","article-title":"PSMA-targeted PET radiotracer [(18)F]DCFPyL as an imaging biomarker in inflammatory bowel disease","volume":"16","author":"Ismail MS","year":"2023","unstructured":"Ismail MS, Peters DE, Rowe SP, et al.. PSMA-targeted PET radiotracer [(18)F]DCFPyL as an imaging biomarker in inflammatory bowel disease. Clin Exp Gastroenterol. 2023, 16:237-47. 10.2147\/CEG.S404009","journal-title":"Clin Exp Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030410","article-title":"Very low prostate PET\/CT PSMA uptake may be misleading in staging radical prostatectomy candidates","volume":"12","author":"Rosenzweig B","year":"2022","unstructured":"Rosenzweig B, Haramaty R, Davidson T, et al.. Very low prostate PET\/CT PSMA uptake may be misleading in staging radical prostatectomy candidates. J Pers Med. 2022, 12:10.3390\/jpm12030410","journal-title":"J Pers Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/405335-the-role-of-prostate-specific-membrane-antigen-psma-pet-ct-in-characterizing-suspected-synchronous-rectal-lesions-in-a-case-of-high-grade-prostatic-adenocarcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T06:36:27Z","timestamp":1756967787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/405335-the-role-of-prostate-specific-membrane-antigen-psma-pet-ct-in-characterizing-suspected-synchronous-rectal-lesions-in-a-case-of-high-grade-prostatic-adenocarcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.91575","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,3]]}}}